New Tool Assesses Recurrence Risk With Pancreatic Neuroendocrine Tumors

TUESDAY, Dec. 30, 2025-- A new tool can help physicians determine which patients with localized pancreatic neuroendocrine tumors (PanNETs) have an increased risk for cancer recurrence, according to a study published online Dec. 17 in JAMA...